Global Valsartan Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Valsartan Industry Forecast” looks at past sales and reviews total world Valsartan sales in 2022, providing a comprehensive analysis by region and market sector of projected Valsartan sales for 2023 through 2029. With Valsartan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valsartan industry.
This Insight Report provides a comprehensive analysis of the global Valsartan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Valsartan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Valsartan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valsartan and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valsartan.
The global Valsartan market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Valsartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Valsartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Valsartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Valsartan players cover Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals and HETERO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Valsartan market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Valsartan market?
What factors are driving Valsartan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Valsartan market opportunities vary by end market size?
How does Valsartan break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Valsartan Industry Forecast” looks at past sales and reviews total world Valsartan sales in 2022, providing a comprehensive analysis by region and market sector of projected Valsartan sales for 2023 through 2029. With Valsartan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valsartan industry.
This Insight Report provides a comprehensive analysis of the global Valsartan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Valsartan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Valsartan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valsartan and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valsartan.
The global Valsartan market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Valsartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Valsartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Valsartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Valsartan players cover Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals and HETERO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Valsartan market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 40 mg Tablets
- 80 mg Tablets
- 160 mg Tablets
- 320 mg Tablets
- Hypertension
- Heart Failure
- Heart Attack
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Sun Pharmaceutical
- Teva
- Mylan
- Alembic Pharmaceuticals
- Lupin
- Aurobindo Pharma
- Macleods Pharmaceuticals
- HETERO
- Torrent Pharmaceuticals
- Huaren Pharmaceutical
- Jubilant Pharma
- Amneal Pharmaceuticals
- Zhejiang Huahai Pharmaceutical
- Square Pharmaceuticals
- Unichem Laboratories
- LG Life Sciences
What is the 10-year outlook for the global Valsartan market?
What factors are driving Valsartan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Valsartan market opportunities vary by end market size?
How does Valsartan break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valsartan Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Valsartan by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Valsartan by Country/Region, 2018, 2022 & 2029
2.2 Valsartan Segment by Type
2.2.1 40 mg Tablets
2.2.2 80 mg Tablets
2.2.3 160 mg Tablets
2.2.4 320 mg Tablets
2.3 Valsartan Sales by Type
2.3.1 Global Valsartan Sales Market Share by Type (2018-2023)
2.3.2 Global Valsartan Revenue and Market Share by Type (2018-2023)
2.3.3 Global Valsartan Sale Price by Type (2018-2023)
2.4 Valsartan Segment by Application
2.4.1 Hypertension
2.4.2 Heart Failure
2.4.3 Heart Attack
2.5 Valsartan Sales by Application
2.5.1 Global Valsartan Sale Market Share by Application (2018-2023)
2.5.2 Global Valsartan Revenue and Market Share by Application (2018-2023)
2.5.3 Global Valsartan Sale Price by Application (2018-2023)
3 GLOBAL VALSARTAN BY COMPANY
3.1 Global Valsartan Breakdown Data by Company
3.1.1 Global Valsartan Annual Sales by Company (2018-2023)
3.1.2 Global Valsartan Sales Market Share by Company (2018-2023)
3.2 Global Valsartan Annual Revenue by Company (2018-2023)
3.2.1 Global Valsartan Revenue by Company (2018-2023)
3.2.2 Global Valsartan Revenue Market Share by Company (2018-2023)
3.3 Global Valsartan Sale Price by Company
3.4 Key Manufacturers Valsartan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valsartan Product Location Distribution
3.4.2 Players Valsartan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VALSARTAN BY GEOGRAPHIC REGION
4.1 World Historic Valsartan Market Size by Geographic Region (2018-2023)
4.1.1 Global Valsartan Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Valsartan Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Valsartan Market Size by Country/Region (2018-2023)
4.2.1 Global Valsartan Annual Sales by Country/Region (2018-2023)
4.2.2 Global Valsartan Annual Revenue by Country/Region (2018-2023)
4.3 Americas Valsartan Sales Growth
4.4 APAC Valsartan Sales Growth
4.5 Europe Valsartan Sales Growth
4.6 Middle East & Africa Valsartan Sales Growth
5 AMERICAS
5.1 Americas Valsartan Sales by Country
5.1.1 Americas Valsartan Sales by Country (2018-2023)
5.1.2 Americas Valsartan Revenue by Country (2018-2023)
5.2 Americas Valsartan Sales by Type
5.3 Americas Valsartan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valsartan Sales by Region
6.1.1 APAC Valsartan Sales by Region (2018-2023)
6.1.2 APAC Valsartan Revenue by Region (2018-2023)
6.2 APAC Valsartan Sales by Type
6.3 APAC Valsartan Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Valsartan by Country
7.1.1 Europe Valsartan Sales by Country (2018-2023)
7.1.2 Europe Valsartan Revenue by Country (2018-2023)
7.2 Europe Valsartan Sales by Type
7.3 Europe Valsartan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Valsartan by Country
8.1.1 Middle East & Africa Valsartan Sales by Country (2018-2023)
8.1.2 Middle East & Africa Valsartan Revenue by Country (2018-2023)
8.2 Middle East & Africa Valsartan Sales by Type
8.3 Middle East & Africa Valsartan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valsartan
10.3 Manufacturing Process Analysis of Valsartan
10.4 Industry Chain Structure of Valsartan
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Valsartan Distributors
11.3 Valsartan Customer
12 WORLD FORECAST REVIEW FOR VALSARTAN BY GEOGRAPHIC REGION
12.1 Global Valsartan Market Size Forecast by Region
12.1.1 Global Valsartan Forecast by Region (2024-2029)
12.1.2 Global Valsartan Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Valsartan Forecast by Type
12.7 Global Valsartan Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Valsartan Product Portfolios and Specifications
13.1.3 Novartis Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical Company Information
13.2.2 Sun Pharmaceutical Valsartan Product Portfolios and Specifications
13.2.3 Sun Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sun Pharmaceutical Main Business Overview
13.2.5 Sun Pharmaceutical Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Valsartan Product Portfolios and Specifications
13.3.3 Teva Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Valsartan Product Portfolios and Specifications
13.4.3 Mylan Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Alembic Pharmaceuticals
13.5.1 Alembic Pharmaceuticals Company Information
13.5.2 Alembic Pharmaceuticals Valsartan Product Portfolios and Specifications
13.5.3 Alembic Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Alembic Pharmaceuticals Main Business Overview
13.5.5 Alembic Pharmaceuticals Latest Developments
13.6 Lupin
13.6.1 Lupin Company Information
13.6.2 Lupin Valsartan Product Portfolios and Specifications
13.6.3 Lupin Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lupin Main Business Overview
13.6.5 Lupin Latest Developments
13.7 Aurobindo Pharma
13.7.1 Aurobindo Pharma Company Information
13.7.2 Aurobindo Pharma Valsartan Product Portfolios and Specifications
13.7.3 Aurobindo Pharma Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Aurobindo Pharma Main Business Overview
13.7.5 Aurobindo Pharma Latest Developments
13.8 Macleods Pharmaceuticals
13.8.1 Macleods Pharmaceuticals Company Information
13.8.2 Macleods Pharmaceuticals Valsartan Product Portfolios and Specifications
13.8.3 Macleods Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Macleods Pharmaceuticals Main Business Overview
13.8.5 Macleods Pharmaceuticals Latest Developments
13.9 HETERO
13.9.1 HETERO Company Information
13.9.2 HETERO Valsartan Product Portfolios and Specifications
13.9.3 HETERO Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 HETERO Main Business Overview
13.9.5 HETERO Latest Developments
13.10 Torrent Pharmaceuticals
13.10.1 Torrent Pharmaceuticals Company Information
13.10.2 Torrent Pharmaceuticals Valsartan Product Portfolios and Specifications
13.10.3 Torrent Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Torrent Pharmaceuticals Main Business Overview
13.10.5 Torrent Pharmaceuticals Latest Developments
13.11 Huaren Pharmaceutical
13.11.1 Huaren Pharmaceutical Company Information
13.11.2 Huaren Pharmaceutical Valsartan Product Portfolios and Specifications
13.11.3 Huaren Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Huaren Pharmaceutical Main Business Overview
13.11.5 Huaren Pharmaceutical Latest Developments
13.12 Jubilant Pharma
13.12.1 Jubilant Pharma Company Information
13.12.2 Jubilant Pharma Valsartan Product Portfolios and Specifications
13.12.3 Jubilant Pharma Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Jubilant Pharma Main Business Overview
13.12.5 Jubilant Pharma Latest Developments
13.13 Amneal Pharmaceuticals
13.13.1 Amneal Pharmaceuticals Company Information
13.13.2 Amneal Pharmaceuticals Valsartan Product Portfolios and Specifications
13.13.3 Amneal Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Amneal Pharmaceuticals Main Business Overview
13.13.5 Amneal Pharmaceuticals Latest Developments
13.14 Zhejiang Huahai Pharmaceutical
13.14.1 Zhejiang Huahai Pharmaceutical Company Information
13.14.2 Zhejiang Huahai Pharmaceutical Valsartan Product Portfolios and Specifications
13.14.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.14.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.15 Square Pharmaceuticals
13.15.1 Square Pharmaceuticals Company Information
13.15.2 Square Pharmaceuticals Valsartan Product Portfolios and Specifications
13.15.3 Square Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Square Pharmaceuticals Main Business Overview
13.15.5 Square Pharmaceuticals Latest Developments
13.16 Unichem Laboratories
13.16.1 Unichem Laboratories Company Information
13.16.2 Unichem Laboratories Valsartan Product Portfolios and Specifications
13.16.3 Unichem Laboratories Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Unichem Laboratories Main Business Overview
13.16.5 Unichem Laboratories Latest Developments
13.17 LG Life Sciences
13.17.1 LG Life Sciences Company Information
13.17.2 LG Life Sciences Valsartan Product Portfolios and Specifications
13.17.3 LG Life Sciences Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 LG Life Sciences Main Business Overview
13.17.5 LG Life Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valsartan Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Valsartan by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Valsartan by Country/Region, 2018, 2022 & 2029
2.2 Valsartan Segment by Type
2.2.1 40 mg Tablets
2.2.2 80 mg Tablets
2.2.3 160 mg Tablets
2.2.4 320 mg Tablets
2.3 Valsartan Sales by Type
2.3.1 Global Valsartan Sales Market Share by Type (2018-2023)
2.3.2 Global Valsartan Revenue and Market Share by Type (2018-2023)
2.3.3 Global Valsartan Sale Price by Type (2018-2023)
2.4 Valsartan Segment by Application
2.4.1 Hypertension
2.4.2 Heart Failure
2.4.3 Heart Attack
2.5 Valsartan Sales by Application
2.5.1 Global Valsartan Sale Market Share by Application (2018-2023)
2.5.2 Global Valsartan Revenue and Market Share by Application (2018-2023)
2.5.3 Global Valsartan Sale Price by Application (2018-2023)
3 GLOBAL VALSARTAN BY COMPANY
3.1 Global Valsartan Breakdown Data by Company
3.1.1 Global Valsartan Annual Sales by Company (2018-2023)
3.1.2 Global Valsartan Sales Market Share by Company (2018-2023)
3.2 Global Valsartan Annual Revenue by Company (2018-2023)
3.2.1 Global Valsartan Revenue by Company (2018-2023)
3.2.2 Global Valsartan Revenue Market Share by Company (2018-2023)
3.3 Global Valsartan Sale Price by Company
3.4 Key Manufacturers Valsartan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valsartan Product Location Distribution
3.4.2 Players Valsartan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VALSARTAN BY GEOGRAPHIC REGION
4.1 World Historic Valsartan Market Size by Geographic Region (2018-2023)
4.1.1 Global Valsartan Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Valsartan Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Valsartan Market Size by Country/Region (2018-2023)
4.2.1 Global Valsartan Annual Sales by Country/Region (2018-2023)
4.2.2 Global Valsartan Annual Revenue by Country/Region (2018-2023)
4.3 Americas Valsartan Sales Growth
4.4 APAC Valsartan Sales Growth
4.5 Europe Valsartan Sales Growth
4.6 Middle East & Africa Valsartan Sales Growth
5 AMERICAS
5.1 Americas Valsartan Sales by Country
5.1.1 Americas Valsartan Sales by Country (2018-2023)
5.1.2 Americas Valsartan Revenue by Country (2018-2023)
5.2 Americas Valsartan Sales by Type
5.3 Americas Valsartan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valsartan Sales by Region
6.1.1 APAC Valsartan Sales by Region (2018-2023)
6.1.2 APAC Valsartan Revenue by Region (2018-2023)
6.2 APAC Valsartan Sales by Type
6.3 APAC Valsartan Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Valsartan by Country
7.1.1 Europe Valsartan Sales by Country (2018-2023)
7.1.2 Europe Valsartan Revenue by Country (2018-2023)
7.2 Europe Valsartan Sales by Type
7.3 Europe Valsartan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Valsartan by Country
8.1.1 Middle East & Africa Valsartan Sales by Country (2018-2023)
8.1.2 Middle East & Africa Valsartan Revenue by Country (2018-2023)
8.2 Middle East & Africa Valsartan Sales by Type
8.3 Middle East & Africa Valsartan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valsartan
10.3 Manufacturing Process Analysis of Valsartan
10.4 Industry Chain Structure of Valsartan
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Valsartan Distributors
11.3 Valsartan Customer
12 WORLD FORECAST REVIEW FOR VALSARTAN BY GEOGRAPHIC REGION
12.1 Global Valsartan Market Size Forecast by Region
12.1.1 Global Valsartan Forecast by Region (2024-2029)
12.1.2 Global Valsartan Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Valsartan Forecast by Type
12.7 Global Valsartan Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Valsartan Product Portfolios and Specifications
13.1.3 Novartis Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical Company Information
13.2.2 Sun Pharmaceutical Valsartan Product Portfolios and Specifications
13.2.3 Sun Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sun Pharmaceutical Main Business Overview
13.2.5 Sun Pharmaceutical Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Valsartan Product Portfolios and Specifications
13.3.3 Teva Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Valsartan Product Portfolios and Specifications
13.4.3 Mylan Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Alembic Pharmaceuticals
13.5.1 Alembic Pharmaceuticals Company Information
13.5.2 Alembic Pharmaceuticals Valsartan Product Portfolios and Specifications
13.5.3 Alembic Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Alembic Pharmaceuticals Main Business Overview
13.5.5 Alembic Pharmaceuticals Latest Developments
13.6 Lupin
13.6.1 Lupin Company Information
13.6.2 Lupin Valsartan Product Portfolios and Specifications
13.6.3 Lupin Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lupin Main Business Overview
13.6.5 Lupin Latest Developments
13.7 Aurobindo Pharma
13.7.1 Aurobindo Pharma Company Information
13.7.2 Aurobindo Pharma Valsartan Product Portfolios and Specifications
13.7.3 Aurobindo Pharma Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Aurobindo Pharma Main Business Overview
13.7.5 Aurobindo Pharma Latest Developments
13.8 Macleods Pharmaceuticals
13.8.1 Macleods Pharmaceuticals Company Information
13.8.2 Macleods Pharmaceuticals Valsartan Product Portfolios and Specifications
13.8.3 Macleods Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Macleods Pharmaceuticals Main Business Overview
13.8.5 Macleods Pharmaceuticals Latest Developments
13.9 HETERO
13.9.1 HETERO Company Information
13.9.2 HETERO Valsartan Product Portfolios and Specifications
13.9.3 HETERO Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 HETERO Main Business Overview
13.9.5 HETERO Latest Developments
13.10 Torrent Pharmaceuticals
13.10.1 Torrent Pharmaceuticals Company Information
13.10.2 Torrent Pharmaceuticals Valsartan Product Portfolios and Specifications
13.10.3 Torrent Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Torrent Pharmaceuticals Main Business Overview
13.10.5 Torrent Pharmaceuticals Latest Developments
13.11 Huaren Pharmaceutical
13.11.1 Huaren Pharmaceutical Company Information
13.11.2 Huaren Pharmaceutical Valsartan Product Portfolios and Specifications
13.11.3 Huaren Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Huaren Pharmaceutical Main Business Overview
13.11.5 Huaren Pharmaceutical Latest Developments
13.12 Jubilant Pharma
13.12.1 Jubilant Pharma Company Information
13.12.2 Jubilant Pharma Valsartan Product Portfolios and Specifications
13.12.3 Jubilant Pharma Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Jubilant Pharma Main Business Overview
13.12.5 Jubilant Pharma Latest Developments
13.13 Amneal Pharmaceuticals
13.13.1 Amneal Pharmaceuticals Company Information
13.13.2 Amneal Pharmaceuticals Valsartan Product Portfolios and Specifications
13.13.3 Amneal Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Amneal Pharmaceuticals Main Business Overview
13.13.5 Amneal Pharmaceuticals Latest Developments
13.14 Zhejiang Huahai Pharmaceutical
13.14.1 Zhejiang Huahai Pharmaceutical Company Information
13.14.2 Zhejiang Huahai Pharmaceutical Valsartan Product Portfolios and Specifications
13.14.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.14.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.15 Square Pharmaceuticals
13.15.1 Square Pharmaceuticals Company Information
13.15.2 Square Pharmaceuticals Valsartan Product Portfolios and Specifications
13.15.3 Square Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Square Pharmaceuticals Main Business Overview
13.15.5 Square Pharmaceuticals Latest Developments
13.16 Unichem Laboratories
13.16.1 Unichem Laboratories Company Information
13.16.2 Unichem Laboratories Valsartan Product Portfolios and Specifications
13.16.3 Unichem Laboratories Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Unichem Laboratories Main Business Overview
13.16.5 Unichem Laboratories Latest Developments
13.17 LG Life Sciences
13.17.1 LG Life Sciences Company Information
13.17.2 LG Life Sciences Valsartan Product Portfolios and Specifications
13.17.3 LG Life Sciences Valsartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 LG Life Sciences Main Business Overview
13.17.5 LG Life Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Valsartan Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Valsartan Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 40 mg Tablets
Table 4. Major Players of 80 mg Tablets
Table 5. Major Players of 160 mg Tablets
Table 6. Major Players of 320 mg Tablets
Table 7. Global Valsartan Sales by Type (2018-2023) & (K Units)
Table 8. Global Valsartan Sales Market Share by Type (2018-2023)
Table 9. Global Valsartan Revenue by Type (2018-2023) & ($ million)
Table 10. Global Valsartan Revenue Market Share by Type (2018-2023)
Table 11. Global Valsartan Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Valsartan Sales by Application (2018-2023) & (K Units)
Table 13. Global Valsartan Sales Market Share by Application (2018-2023)
Table 14. Global Valsartan Revenue by Application (2018-2023)
Table 15. Global Valsartan Revenue Market Share by Application (2018-2023)
Table 16. Global Valsartan Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Valsartan Sales by Company (2018-2023) & (K Units)
Table 18. Global Valsartan Sales Market Share by Company (2018-2023)
Table 19. Global Valsartan Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Valsartan Revenue Market Share by Company (2018-2023)
Table 21. Global Valsartan Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Valsartan Producing Area Distribution and Sales Area
Table 23. Players Valsartan Products Offered
Table 24. Valsartan Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Valsartan Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Valsartan Sales Market Share Geographic Region (2018-2023)
Table 29. Global Valsartan Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Valsartan Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Valsartan Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Valsartan Sales Market Share by Country/Region (2018-2023)
Table 33. Global Valsartan Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Valsartan Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Valsartan Sales by Country (2018-2023) & (K Units)
Table 36. Americas Valsartan Sales Market Share by Country (2018-2023)
Table 37. Americas Valsartan Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Valsartan Revenue Market Share by Country (2018-2023)
Table 39. Americas Valsartan Sales by Type (2018-2023) & (K Units)
Table 40. Americas Valsartan Sales by Application (2018-2023) & (K Units)
Table 41. APAC Valsartan Sales by Region (2018-2023) & (K Units)
Table 42. APAC Valsartan Sales Market Share by Region (2018-2023)
Table 43. APAC Valsartan Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Valsartan Revenue Market Share by Region (2018-2023)
Table 45. APAC Valsartan Sales by Type (2018-2023) & (K Units)
Table 46. APAC Valsartan Sales by Application (2018-2023) & (K Units)
Table 47. Europe Valsartan Sales by Country (2018-2023) & (K Units)
Table 48. Europe Valsartan Sales Market Share by Country (2018-2023)
Table 49. Europe Valsartan Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Valsartan Revenue Market Share by Country (2018-2023)
Table 51. Europe Valsartan Sales by Type (2018-2023) & (K Units)
Table 52. Europe Valsartan Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Valsartan Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Valsartan Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Valsartan Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Valsartan Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Valsartan Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Valsartan Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Valsartan
Table 60. Key Market Challenges & Risks of Valsartan
Table 61. Key Industry Trends of Valsartan
Table 62. Valsartan Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Valsartan Distributors List
Table 65. Valsartan Customer List
Table 66. Global Valsartan Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Valsartan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Valsartan Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Valsartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Valsartan Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Valsartan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Valsartan Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Valsartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Valsartan Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Valsartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Valsartan Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Valsartan Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Valsartan Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Valsartan Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Novartis Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis Valsartan Product Portfolios and Specifications
Table 82. Novartis Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. Sun Pharmaceutical Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 86. Sun Pharmaceutical Valsartan Product Portfolios and Specifications
Table 87. Sun Pharmaceutical Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Sun Pharmaceutical Main Business
Table 89. Sun Pharmaceutical Latest Developments
Table 90. Teva Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 91. Teva Valsartan Product Portfolios and Specifications
Table 92. Teva Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Teva Main Business
Table 94. Teva Latest Developments
Table 95. Mylan Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 96. Mylan Valsartan Product Portfolios and Specifications
Table 97. Mylan Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Mylan Main Business
Table 99. Mylan Latest Developments
Table 100. Alembic Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 101. Alembic Pharmaceuticals Valsartan Product Portfolios and Specifications
Table 102. Alembic Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Alembic Pharmaceuticals Main Business
Table 104. Alembic Pharmaceuticals Latest Developments
Table 105. Lupin Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 106. Lupin Valsartan Product Portfolios and Specifications
Table 107. Lupin Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Lupin Main Business
Table 109. Lupin Latest Developments
Table 110. Aurobindo Pharma Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 111. Aurobindo Pharma Valsartan Product Portfolios and Specifications
Table 112. Aurobindo Pharma Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Aurobindo Pharma Main Business
Table 114. Aurobindo Pharma Latest Developments
Table 115. Macleods Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 116. Macleods Pharmaceuticals Valsartan Product Portfolios and Specifications
Table 117. Macleods Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Macleods Pharmaceuticals Main Business
Table 119. Macleods Pharmaceuticals Latest Developments
Table 120. HETERO Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 121. HETERO Valsartan Product Portfolios and Specifications
Table 122. HETERO Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. HETERO Main Business
Table 124. HETERO Latest Developments
Table 125. Torrent Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 126. Torrent Pharmaceuticals Valsartan Product Portfolios and Specifications
Table 127. Torrent Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Torrent Pharmaceuticals Main Business
Table 129. Torrent Pharmaceuticals Latest Developments
Table 130. Huaren Pharmaceutical Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 131. Huaren Pharmaceutical Valsartan Product Portfolios and Specifications
Table 132. Huaren Pharmaceutical Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Huaren Pharmaceutical Main Business
Table 134. Huaren Pharmaceutical Latest Developments
Table 135. Jubilant Pharma Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 136. Jubilant Pharma Valsartan Product Portfolios and Specifications
Table 137. Jubilant Pharma Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Jubilant Pharma Main Business
Table 139. Jubilant Pharma Latest Developments
Table 140. Amneal Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 141. Amneal Pharmaceuticals Valsartan Product Portfolios and Specifications
Table 142. Amneal Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Amneal Pharmaceuticals Main Business
Table 144. Amneal Pharmaceuticals Latest Developments
Table 145. Zhejiang Huahai Pharmaceutical Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 146. Zhejiang Huahai Pharmaceutical Valsartan Product Portfolios and Specifications
Table 147. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Zhejiang Huahai Pharmaceutical Main Business
Table 149. Zhejiang Huahai Pharmaceutical Latest Developments
Table 150. Square Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 151. Square Pharmaceuticals Valsartan Product Portfolios and Specifications
Table 152. Square Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Square Pharmaceuticals Main Business
Table 154. Square Pharmaceuticals Latest Developments
Table 155. Unichem Laboratories Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 156. Unichem Laboratories Valsartan Product Portfolios and Specifications
Table 157. Unichem Laboratories Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Unichem Laboratories Main Business
Table 159. Unichem Laboratories Latest Developments
Table 160. LG Life Sciences Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 161. LG Life Sciences Valsartan Product Portfolios and Specifications
Table 162. LG Life Sciences Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. LG Life Sciences Main Business
Table 164. LG Life Sciences Latest Developments
Table 1. Valsartan Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Valsartan Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 40 mg Tablets
Table 4. Major Players of 80 mg Tablets
Table 5. Major Players of 160 mg Tablets
Table 6. Major Players of 320 mg Tablets
Table 7. Global Valsartan Sales by Type (2018-2023) & (K Units)
Table 8. Global Valsartan Sales Market Share by Type (2018-2023)
Table 9. Global Valsartan Revenue by Type (2018-2023) & ($ million)
Table 10. Global Valsartan Revenue Market Share by Type (2018-2023)
Table 11. Global Valsartan Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Valsartan Sales by Application (2018-2023) & (K Units)
Table 13. Global Valsartan Sales Market Share by Application (2018-2023)
Table 14. Global Valsartan Revenue by Application (2018-2023)
Table 15. Global Valsartan Revenue Market Share by Application (2018-2023)
Table 16. Global Valsartan Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Valsartan Sales by Company (2018-2023) & (K Units)
Table 18. Global Valsartan Sales Market Share by Company (2018-2023)
Table 19. Global Valsartan Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Valsartan Revenue Market Share by Company (2018-2023)
Table 21. Global Valsartan Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Valsartan Producing Area Distribution and Sales Area
Table 23. Players Valsartan Products Offered
Table 24. Valsartan Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Valsartan Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Valsartan Sales Market Share Geographic Region (2018-2023)
Table 29. Global Valsartan Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Valsartan Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Valsartan Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Valsartan Sales Market Share by Country/Region (2018-2023)
Table 33. Global Valsartan Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Valsartan Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Valsartan Sales by Country (2018-2023) & (K Units)
Table 36. Americas Valsartan Sales Market Share by Country (2018-2023)
Table 37. Americas Valsartan Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Valsartan Revenue Market Share by Country (2018-2023)
Table 39. Americas Valsartan Sales by Type (2018-2023) & (K Units)
Table 40. Americas Valsartan Sales by Application (2018-2023) & (K Units)
Table 41. APAC Valsartan Sales by Region (2018-2023) & (K Units)
Table 42. APAC Valsartan Sales Market Share by Region (2018-2023)
Table 43. APAC Valsartan Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Valsartan Revenue Market Share by Region (2018-2023)
Table 45. APAC Valsartan Sales by Type (2018-2023) & (K Units)
Table 46. APAC Valsartan Sales by Application (2018-2023) & (K Units)
Table 47. Europe Valsartan Sales by Country (2018-2023) & (K Units)
Table 48. Europe Valsartan Sales Market Share by Country (2018-2023)
Table 49. Europe Valsartan Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Valsartan Revenue Market Share by Country (2018-2023)
Table 51. Europe Valsartan Sales by Type (2018-2023) & (K Units)
Table 52. Europe Valsartan Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Valsartan Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Valsartan Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Valsartan Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Valsartan Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Valsartan Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Valsartan Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Valsartan
Table 60. Key Market Challenges & Risks of Valsartan
Table 61. Key Industry Trends of Valsartan
Table 62. Valsartan Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Valsartan Distributors List
Table 65. Valsartan Customer List
Table 66. Global Valsartan Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Valsartan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Valsartan Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Valsartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Valsartan Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Valsartan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Valsartan Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Valsartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Valsartan Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Valsartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Valsartan Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Valsartan Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Valsartan Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Valsartan Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Novartis Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis Valsartan Product Portfolios and Specifications
Table 82. Novartis Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. Sun Pharmaceutical Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 86. Sun Pharmaceutical Valsartan Product Portfolios and Specifications
Table 87. Sun Pharmaceutical Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Sun Pharmaceutical Main Business
Table 89. Sun Pharmaceutical Latest Developments
Table 90. Teva Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 91. Teva Valsartan Product Portfolios and Specifications
Table 92. Teva Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Teva Main Business
Table 94. Teva Latest Developments
Table 95. Mylan Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 96. Mylan Valsartan Product Portfolios and Specifications
Table 97. Mylan Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Mylan Main Business
Table 99. Mylan Latest Developments
Table 100. Alembic Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 101. Alembic Pharmaceuticals Valsartan Product Portfolios and Specifications
Table 102. Alembic Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Alembic Pharmaceuticals Main Business
Table 104. Alembic Pharmaceuticals Latest Developments
Table 105. Lupin Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 106. Lupin Valsartan Product Portfolios and Specifications
Table 107. Lupin Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Lupin Main Business
Table 109. Lupin Latest Developments
Table 110. Aurobindo Pharma Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 111. Aurobindo Pharma Valsartan Product Portfolios and Specifications
Table 112. Aurobindo Pharma Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Aurobindo Pharma Main Business
Table 114. Aurobindo Pharma Latest Developments
Table 115. Macleods Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 116. Macleods Pharmaceuticals Valsartan Product Portfolios and Specifications
Table 117. Macleods Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Macleods Pharmaceuticals Main Business
Table 119. Macleods Pharmaceuticals Latest Developments
Table 120. HETERO Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 121. HETERO Valsartan Product Portfolios and Specifications
Table 122. HETERO Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. HETERO Main Business
Table 124. HETERO Latest Developments
Table 125. Torrent Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 126. Torrent Pharmaceuticals Valsartan Product Portfolios and Specifications
Table 127. Torrent Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Torrent Pharmaceuticals Main Business
Table 129. Torrent Pharmaceuticals Latest Developments
Table 130. Huaren Pharmaceutical Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 131. Huaren Pharmaceutical Valsartan Product Portfolios and Specifications
Table 132. Huaren Pharmaceutical Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Huaren Pharmaceutical Main Business
Table 134. Huaren Pharmaceutical Latest Developments
Table 135. Jubilant Pharma Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 136. Jubilant Pharma Valsartan Product Portfolios and Specifications
Table 137. Jubilant Pharma Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Jubilant Pharma Main Business
Table 139. Jubilant Pharma Latest Developments
Table 140. Amneal Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 141. Amneal Pharmaceuticals Valsartan Product Portfolios and Specifications
Table 142. Amneal Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Amneal Pharmaceuticals Main Business
Table 144. Amneal Pharmaceuticals Latest Developments
Table 145. Zhejiang Huahai Pharmaceutical Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 146. Zhejiang Huahai Pharmaceutical Valsartan Product Portfolios and Specifications
Table 147. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Zhejiang Huahai Pharmaceutical Main Business
Table 149. Zhejiang Huahai Pharmaceutical Latest Developments
Table 150. Square Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 151. Square Pharmaceuticals Valsartan Product Portfolios and Specifications
Table 152. Square Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Square Pharmaceuticals Main Business
Table 154. Square Pharmaceuticals Latest Developments
Table 155. Unichem Laboratories Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 156. Unichem Laboratories Valsartan Product Portfolios and Specifications
Table 157. Unichem Laboratories Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Unichem Laboratories Main Business
Table 159. Unichem Laboratories Latest Developments
Table 160. LG Life Sciences Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 161. LG Life Sciences Valsartan Product Portfolios and Specifications
Table 162. LG Life Sciences Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. LG Life Sciences Main Business
Table 164. LG Life Sciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Valsartan
Figure 2. Valsartan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valsartan Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Valsartan Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Valsartan Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 40 mg Tablets
Figure 10. Product Picture of 80 mg Tablets
Figure 11. Product Picture of 160 mg Tablets
Figure 12. Product Picture of 320 mg Tablets
Figure 13. Global Valsartan Sales Market Share by Type in 2022
Figure 14. Global Valsartan Revenue Market Share by Type (2018-2023)
Figure 15. Valsartan Consumed in Hypertension
Figure 16. Global Valsartan Market: Hypertension (2018-2023) & (K Units)
Figure 17. Valsartan Consumed in Heart Failure
Figure 18. Global Valsartan Market: Heart Failure (2018-2023) & (K Units)
Figure 19. Valsartan Consumed in Heart Attack
Figure 20. Global Valsartan Market: Heart Attack (2018-2023) & (K Units)
Figure 21. Global Valsartan Sales Market Share by Application (2022)
Figure 22. Global Valsartan Revenue Market Share by Application in 2022
Figure 23. Valsartan Sales Market by Company in 2022 (K Units)
Figure 24. Global Valsartan Sales Market Share by Company in 2022
Figure 25. Valsartan Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Valsartan Revenue Market Share by Company in 2022
Figure 27. Global Valsartan Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Valsartan Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Valsartan Sales 2018-2023 (K Units)
Figure 30. Americas Valsartan Revenue 2018-2023 ($ Millions)
Figure 31. APAC Valsartan Sales 2018-2023 (K Units)
Figure 32. APAC Valsartan Revenue 2018-2023 ($ Millions)
Figure 33. Europe Valsartan Sales 2018-2023 (K Units)
Figure 34. Europe Valsartan Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Valsartan Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Valsartan Revenue 2018-2023 ($ Millions)
Figure 37. Americas Valsartan Sales Market Share by Country in 2022
Figure 38. Americas Valsartan Revenue Market Share by Country in 2022
Figure 39. Americas Valsartan Sales Market Share by Type (2018-2023)
Figure 40. Americas Valsartan Sales Market Share by Application (2018-2023)
Figure 41. United States Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Valsartan Sales Market Share by Region in 2022
Figure 46. APAC Valsartan Revenue Market Share by Regions in 2022
Figure 47. APAC Valsartan Sales Market Share by Type (2018-2023)
Figure 48. APAC Valsartan Sales Market Share by Application (2018-2023)
Figure 49. China Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Valsartan Sales Market Share by Country in 2022
Figure 57. Europe Valsartan Revenue Market Share by Country in 2022
Figure 58. Europe Valsartan Sales Market Share by Type (2018-2023)
Figure 59. Europe Valsartan Sales Market Share by Application (2018-2023)
Figure 60. Germany Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Valsartan Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Valsartan Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Valsartan Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Valsartan Sales Market Share by Application (2018-2023)
Figure 69. Egypt Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Valsartan in 2022
Figure 75. Manufacturing Process Analysis of Valsartan
Figure 76. Industry Chain Structure of Valsartan
Figure 77. Channels of Distribution
Figure 78. Global Valsartan Sales Market Forecast by Region (2024-2029)
Figure 79. Global Valsartan Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Valsartan Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Valsartan Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Valsartan Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Valsartan Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Valsartan
Figure 2. Valsartan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valsartan Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Valsartan Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Valsartan Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 40 mg Tablets
Figure 10. Product Picture of 80 mg Tablets
Figure 11. Product Picture of 160 mg Tablets
Figure 12. Product Picture of 320 mg Tablets
Figure 13. Global Valsartan Sales Market Share by Type in 2022
Figure 14. Global Valsartan Revenue Market Share by Type (2018-2023)
Figure 15. Valsartan Consumed in Hypertension
Figure 16. Global Valsartan Market: Hypertension (2018-2023) & (K Units)
Figure 17. Valsartan Consumed in Heart Failure
Figure 18. Global Valsartan Market: Heart Failure (2018-2023) & (K Units)
Figure 19. Valsartan Consumed in Heart Attack
Figure 20. Global Valsartan Market: Heart Attack (2018-2023) & (K Units)
Figure 21. Global Valsartan Sales Market Share by Application (2022)
Figure 22. Global Valsartan Revenue Market Share by Application in 2022
Figure 23. Valsartan Sales Market by Company in 2022 (K Units)
Figure 24. Global Valsartan Sales Market Share by Company in 2022
Figure 25. Valsartan Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Valsartan Revenue Market Share by Company in 2022
Figure 27. Global Valsartan Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Valsartan Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Valsartan Sales 2018-2023 (K Units)
Figure 30. Americas Valsartan Revenue 2018-2023 ($ Millions)
Figure 31. APAC Valsartan Sales 2018-2023 (K Units)
Figure 32. APAC Valsartan Revenue 2018-2023 ($ Millions)
Figure 33. Europe Valsartan Sales 2018-2023 (K Units)
Figure 34. Europe Valsartan Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Valsartan Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Valsartan Revenue 2018-2023 ($ Millions)
Figure 37. Americas Valsartan Sales Market Share by Country in 2022
Figure 38. Americas Valsartan Revenue Market Share by Country in 2022
Figure 39. Americas Valsartan Sales Market Share by Type (2018-2023)
Figure 40. Americas Valsartan Sales Market Share by Application (2018-2023)
Figure 41. United States Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Valsartan Sales Market Share by Region in 2022
Figure 46. APAC Valsartan Revenue Market Share by Regions in 2022
Figure 47. APAC Valsartan Sales Market Share by Type (2018-2023)
Figure 48. APAC Valsartan Sales Market Share by Application (2018-2023)
Figure 49. China Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Valsartan Sales Market Share by Country in 2022
Figure 57. Europe Valsartan Revenue Market Share by Country in 2022
Figure 58. Europe Valsartan Sales Market Share by Type (2018-2023)
Figure 59. Europe Valsartan Sales Market Share by Application (2018-2023)
Figure 60. Germany Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Valsartan Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Valsartan Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Valsartan Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Valsartan Sales Market Share by Application (2018-2023)
Figure 69. Egypt Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Valsartan Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Valsartan in 2022
Figure 75. Manufacturing Process Analysis of Valsartan
Figure 76. Industry Chain Structure of Valsartan
Figure 77. Channels of Distribution
Figure 78. Global Valsartan Sales Market Forecast by Region (2024-2029)
Figure 79. Global Valsartan Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Valsartan Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Valsartan Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Valsartan Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Valsartan Revenue Market Share Forecast by Application (2024-2029)
